Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) — Capital Reinvestment Ratio
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥55.69 Million) in capital expenditures (CN¥5.26 Million). See 603811 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Cheng Yi Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Zhejiang Cheng Yi Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods. Check 603811 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see market cap of Zhejiang Cheng Yi Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | CN¥205.72 Million | CN¥59.89 Million | ▼ -20.0% |
| 2023 | 0.36x | CN¥194.78 Million | CN¥70.85 Million | ▼ -76.1% |
| 2022 | 1.52x | CN¥165.94 Million | CN¥252.85 Million | ▲ +63.0% |
| 2021 | 0.93x | CN¥143.49 Million | CN¥134.11 Million | ▲ +15.7% |
| 2020 | 0.81x | CN¥177.81 Million | CN¥143.67 Million | ▼ -20.4% |
| 2019 | 1.02x | CN¥181.01 Million | CN¥183.81 Million | ▼ -49.8% |
| 2018 | 2.02x | CN¥134.30 Million | CN¥271.52 Million | ▲ +255.2% |
| 2017 | 0.57x | CN¥66.75 Million | CN¥37.99 Million | ▲ +150.2% |
| 2016 | 0.23x | CN¥95.08 Million | CN¥21.63 Million | ▲ +11.1% |
| 2015 | 0.20x | CN¥81.94 Million | CN¥16.79 Million | ▼ -31.1% |
| 2014 | 0.30x | CN¥84.11 Million | CN¥25.01 Million | ▼ -39.2% |
| 2013 | 0.49x | CN¥48.19 Million | CN¥23.57 Million | ▲ +2.9% |
| 2012 | 0.48x | CN¥37.96 Million | CN¥18.05 Million | ▼ -65.4% |
| 2011 | 1.37x | CN¥10.04 Million | CN¥13.78 Million | — |